The Leiden University Medical Center and Amsterdam UMC are launching a clinical study to evaluate the efficacy, safety, affordability, and accessibility of CAR-T cell therapy for patients with severe autoimmune diseases. The National healthcare Institute and the Dutch research council are supporting this initiative with a €14.6 million grant from the research program ‘Potentially Promising Care’. The study is expected to last six years.
Read moreCalendar
Key points LUMC
Data driven healthcare & AI
Data-driven healthcare & AI refers to the digital transformation within our core tasks. We believe that data-driven healthcare & AI make a valuable contribution.
Read more (in Dutch)Regenerative medicine
Regenerative medicine refers to innovative treatments aimed at function repair in damaged cells, tissues and organs.
Read more (in Dutch)Population health
Population health refers for sustainable healthcare with a focus on improving people's health.
Read more (in Dutch)&width=710&height=710)
Specialized centers
Leiden University Medical Center (LUMC) has several specialized centers. Here the knowledge and expertise of multiple departments come together for the best possible care. Information in Dutch.